Efficacy, Safety and Predictors of Response to Rituximab in Treatment of Iraqi Patients with Active Rheumatoid Arthritis
Background: Rituximab (RTX) is an anti-CD20 chimeric monoclonal antibody which effectively depletes B cells and is used for treating rheumatoid arthritis (RA). Objectives: To assess the efficacy and safety of RTX and to evaluate the predictors of response to RTX in the treatment of Iraqi patients wi...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
University of Anbar
2019-06-01
|
| Series: | Al-Anbar Medical Journal |
| Subjects: | |
| Online Access: | https://amj.uoanbar.edu.iq/article_170886_06a9f734f2b014839bf3a1c5321f2cb4.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|